
Gout Therapies Allopurinol, Febuxostat Do Not Increase Retinal Microvascular Disorder Risk
There is no difference in the risk of retinal microvascular disorders between allopurinol and febuxostat initiators, according to a recent cohort study on patients initiating both medications to treat gout. Recent studies comparing urate-lowering therapies …